MBL and C1q compete for interaction with human endothelial cells

Area of Science:

• Immunology
• Cell Biology
• Complement System

Background:

• C1q initiates the classical complement pathway by binding to endothelial cells.
• Mannose-binding lectin (MBL) is structurally and functionally similar to C1q.
• Endothelial cells play a crucial role in immune responses and vascular homeostasis.

Purpose of the Study:

• To investigate the interaction of MBL with human umbilical vein endothelial cells (HUVEC).
• To determine if MBL and C1q share common binding sites on endothelial cells.
• To explore the functional consequences of MBL-endothelial cell interactions.

Main Methods:

• Purification of C1q and MBL from human plasma.
• Flow cytometry to assess MBL and C1q binding to HUVEC.
• Cross-competition experiments using labeled MBL and C1q.
• Stimulation of HUVEC with LPS and MBL to measure cytokine production.

Main Results:

• MBL demonstrated dose-dependent binding to HUVEC, similar to C1q, especially under calcium-free conditions.
• Specific binding of MBL to HUVEC was confirmed through pre-incubation inhibition studies.
• MBL and C1q competitively inhibited each other's binding to HUVEC, suggesting a shared receptor.
• LPS activation increased binding of both MBL and C1q, while MBL stimulation did not significantly increase cytokine production.

Conclusions:

• MBL and C1q likely bind to a common receptor on endothelial cells.
• The interaction of MBL and C1q with endothelial cell receptors may be implicated in inflammatory processes.
• This interaction could be involved in the clearance of pathogens and apoptotic cells.